Summary of Schedule Reconciling Selected Non-GAAP Financial Measures

(unaudited, in millions, except for per share amounts)

Quarter Ended October 1, 2017

GAAP

Non-GAAP
Adjustments

Non-GAAP

Net sales

$

475.3

$

—

$

475.3

Gross profit

$

304.1

$

2.1

$

306.2

Operating income

$

75.4

$

84.6

$

160.0

Net income

$

102.0

$

26.2

$

128.2

Diluted earnings per share

$

0.87

$

0.22

$

1.09

Consolidated Condensed Statements of Income

(unaudited, in millions, except for per share amounts)

Quarter Ended

Twelve Months Ended

Oct 1,
2017

Jul 2,
2017

Oct 2,
2016

Oct 1,
2017

Oct 2,
2016

Net sales

$

475.3

$

458.1

$

450.1

$

1,811.8

$

1,655.0

Cost of sales

171.2

165.4

168.3

654.3

717.9

Gross profit

$

304.1

$

292.7

$

281.8

$

1,157.5

$

937.1

Operating expenses

Selling, general and administrative

$

87.3

$

76.4

$

86.3

$

329.0

$

321.0

Research and development

87.3

85.1

83.5

341.6

309.1

Amortization of intangible assets

50.1

49.6

45.6

191.7

161.2

Restructuring, severance and facilities charges

4.0

11.2

2.4

23.2

60.7

Acquisition and divestiture related costs

—

0.4

0.2

1.7

31.4

Total operating expenses

$

228.7

$

222.7

$

218.0

$

887.2

$

883.4

Operating income

$

75.4

$

70.0

$

63.8

$

270.3

$

53.7

Interest and other expense, net

(22.1)

(58.7)

(27.9)

(134.2)

(79.1)

Income (loss) before income taxes

$

53.3

$

11.3

$

35.9

$

136.1

$

(25.4)

Provision for (benefit from) income taxes

(48.7)

(2.3)

(4.6)

(40.2)

7.2

Net income (loss)

$

102.0

$

13.6

$

40.5

$

176.3

$

(32.6)

Earnings (loss) per share

Basic

$

0.88

$

0.12

$

0.36

$

1.54

$

(0.31)

Diluted

$

0.87

$

0.12

$

0.35

$

1.51

$

(0.31)

Weighted-average common shares outstanding

Basic

115.3

115.0

112.4

114.9

107.0

Diluted

117.7

117.2

115.4

117.1

107.0